INF:LSEInforma Plc Analysis
Data as of 2026-06-05 - not real-time
£831.80
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Informa plc trades at £831.8, just below the short‑term resistance of £833 and above its 20‑day (£809.45) and 50‑day (£799.70) moving averages, indicating a modest technical bounce. The MACD is bullish (histogram +1.09) and RSI sits at 59.6, suggesting momentum is still intact, while a decreasing volume trend tempers enthusiasm. Valuation metrics are mixed: the trailing P/E of 831.8 is dramatically above the industry average of 17.2, yet the DCF‑derived fair value of £874.2 implies about 23% upside, and the forward P/E of 12.6 looks reasonable. The stock’s beta (~0.38) and 30‑day volatility (~19%) point to relatively low market risk, and the dividend yield of 2.68% with a 25.8% payout ratio appears sustainable given positive operating cash flow.
Fundamentally, INF delivers 8% revenue growth and a solid gross margin of 38%, but profit margins are razor‑thin (0.27%) and ROE is negative, reflecting high debt (£3.49bn) and a debt‑to‑equity of 55.7. Free cash flow remains healthy, supporting the dividend and providing cushion against the upcoming FY‑2026 guidance update, where Citi notes uncertainty from the Middle‑East conflict on the events portfolio. Analyst consensus is a “Buy” with a median target of £1,020, underscoring long‑run upside despite short‑term geopolitical headwinds. Investors should watch the guidance release on 18 June for clues on event‑related revenue, while the technical profile suggests a cautious hold now and a buying opportunity on any pull‑back toward the support level of £774.2.
Fundamentally, INF delivers 8% revenue growth and a solid gross margin of 38%, but profit margins are razor‑thin (0.27%) and ROE is negative, reflecting high debt (£3.49bn) and a debt‑to‑equity of 55.7. Free cash flow remains healthy, supporting the dividend and providing cushion against the upcoming FY‑2026 guidance update, where Citi notes uncertainty from the Middle‑East conflict on the events portfolio. Analyst consensus is a “Buy” with a median target of £1,020, underscoring long‑run upside despite short‑term geopolitical headwinds. Investors should watch the guidance release on 18 June for clues on event‑related revenue, while the technical profile suggests a cautious hold now and a buying opportunity on any pull‑back toward the support level of £774.2.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near short‑term resistance at £833
- Decreasing volume trend
- Uncertainty around FY‑2026 guidance due to Middle‑East conflict
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF fair value indicating ~23% upside
- Bullish MACD and RSI still in neutral‑high zone
- Analyst consensus buy with median target ~£1,020
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Sustainable dividend yield of 2.68% with low payout ratio
- Positive free cash flow despite high debt
- Revenue growth of 8% and diversified global event portfolio
Key Metrics & Analysis
Financial Health
Revenue Growth8.00%
Profit Margin0.27%
P/E Ratio831.8
ROE-2.14%
ROA3.83%
Debt/Equity55.69
P/B Ratio1.9
Op. Cash Flow£876.3M
Free Cash Flow£765.3M
Industry P/E17.2
Technical Analysis
TrendNeutral
RSI59.6
Support£774.20
Resistance£833.00
MA 20£809.45
MA 50£799.70
MA 200£866.54
MACDBullish
VolumeDecreasing
Fear & Greed Index93.55
Valuation
Fair Value£874.23
Target Price£1,023.87
Upside/Downside23.09%
GradeOvervalued
TypeValue
Dividend Yield2.68%
Risk Assessment
Beta0.38
Volatility19.03%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.